| Item type |
デフォルトアイテムタイプ_（フル）(1) |
| 公開日 |
2023-03-18 |
| タイトル |
|
|
タイトル |
An overview of stereotactic body radiation therapy for hepatocellular carcinoma |
|
言語 |
en |
| 作成者 |
Kimura, Tomoki
Doi, Yoshiko
Takahashi, Sigeo
Kubo, Katsumaro
Imano, Nobuki
Takeuchi, Yuki
Takahashi, Ippei
Nishibuchi, Ikuno
Murakami, Yuji
Kenjo, Masahiro
Nagata, Yasushi
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 権利情報 |
|
|
権利情報 |
This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Gastroenterology and Hepatology on 30 Mar 2020, available online: http://www.tandfonline.com/10.1080/17474124.2020.1744434. |
| 権利情報 |
|
|
権利情報 |
This is not the published version. Please cite only the published version. この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。 |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Stereotactic body radiotherapy (SBRT) |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
hepatocellular carcinoma (HCC) |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
resection |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
radiofrequency ablation (RFA) |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
transarterial chemoembolization (TACE) |
| 内容記述 |
|
|
内容記述 |
Introduction: According to several guidelines, stereotactic body radiation therapy (SBRT) for early hepatocellular carcinoma (HCC) can be considered an alternative to other modalities, such as resection, radiofrequency ablation (RFA), and transarterial chemoembolization (TACE), or when these therapies have failed or are contraindicated. This article reviews the current status of SBRT for the treatment of HCC. Areas covered: From the results of many retrospective reports, SBRT is a promising modality with an excellent local control of almost 90% at 2–3 years and acceptable toxicities. Currently there are no randomized trials to compare SBRT and other modalities, such as resection, RFA, and TACE, but many retrospective reports and propensity score matching have shown that SBRT is comparable to the different modalities. Repeated SBRT for intra-hepatic recurrent HCC also resulted in high local control with safety and satisfactory overall survival, which were comparable to those of other curative local treatments. Expert opinion: Despite the good results of SBRT, the conclusions of the comparisons of SBRT and other modalities are still controversial. Further studies, including randomized phase III studies to define that patients are more suitable for each curative local treatment, are needed. |
|
言語 |
en |
| 出版者 |
|
|
出版者 |
Taylor and Francis |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 出版タイプ |
|
|
出版タイプ |
AO |
|
出版タイプResource |
http://purl.org/coar/version/c_b1a7d7d4d402bcce |
| 関連情報 |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.1080/17474124.2020.1744434 |
| 関連情報 |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1080/17474124.2020.1744434 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1747-4124 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1747-4132 |
| 開始ページ |
|
|
開始ページ |
271 |
| 書誌情報 |
Expert Review of Gastroenterology and Hepatology
Expert Review of Gastroenterology and Hepatology
巻 14,
号 4,
p. 271-279,
発行日 2020-03-30
|
| 旧ID |
51079 |
ExpRevGastroHepatol_14_271.pdf (499.5 KB)
